Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins.
Allo-anti-M often has an immunoglobulin G (IgG) component but is rarely clinically significant. We report a case of hemolytic disease of the fetus and newborn along with prolonged anemia in newborn twins that persisted for up to 70 days postbirth. The aim was to diagnose and successfully manage hemolytic disease of newborn (HDN) due to maternal alloimmunization. Direct antiglobulin test (DAT), antigen typing, irregular antibody screening and identification were done by polyspecific antihuman globulin cards and standard tube method. At presentation, the newborn twins (T1, T2) had HDN with resultant low reticulocyte count and prolonged anemia, which continued for up to 70 days of life. Blood group of the twins and the mother was O RhD positive. DAT of the both newborns at birth was negative. Anti-M was detected in mothers as well as newborns. Type of antibody in mother was IgG and IgM type whereas in twins it was IgG type only. M antigen negative blood was transfused thrice to twin-1 and twice to twin-2. Recurring reduction of the hematocrit along with low reticulocyte count and normal other cell line indicated a pure red cell aplastic state. Anti-M is capable of causing HDN as well as prolonged anemia (red cell aplasia) due to its ability to destroy the erythroid precursor cells. Newborns with anemia should be evaluated for all the possible causes to establish a diagnosis and its efficient management. Mother should be closely monitored for future pregnancies as well.
Department of Blood Bank, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Satyam
S
Arora
Department of Blood Bank, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Veena
V
Doda
Department of Paediatrics, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Arti
A
Maria
Department of Blood Bank, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Urvershi
U
Kotwal
Department of Paediatrics, Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Saurabh
S
Goyal
Anti-M alloimmunization; hemolytic disease of newborn; pure red cell aplasia